International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8337650
Original Article
An Insight into Reasons For Increase in the Proportion of Hypermature Cataract and Its Complications on Presentation Due to Covid-19 Related Delay
 ,
Published
Aug. 31, 2023
Abstract

Purpose: To assess  the increase in the  proportion of hypermature cataract ,associated  complications  and to evaluate the reasons for delayed presentation during the era of COVID 19 pandemic .

Materials and Methods: an observational and interview based study was undertaken among -398 patients  with hypermature cataract, over a year (post COVID 19 lockdown) in the Ophthalmology department of Mysore medical college and research institute. Presence of complications like phacolytic glaucoma and subluxations was noted. Increase in the proportion of hypermature cataract was calculated  and compared with the previous year morbidity , resulting from hypermaturity , from institutional records .Reasons for  delayed presentation was evaluated with standard questionnaire.

Results: A two fold increase in the proportion of hypermature cataract was observed in our study during the study period. Among 398 cases, (152 )38.19 % were male patients and (246 ) 61.8% were female patients. Majority of patients belonged to age group of 61 to 70 years . About 69% (  270) were hailing from rural area, whereas the remaining 31% (128) patients were from the urban area .76(19%)patients had more than one reason for delayed presentation . Elective OT shut down , lack  of public  transportation , lockdown , fear of being tested as COVID positive followed by isolation , systemic illness , reluctance  by  caretakers  were some of the other reasons.

Conclusion: as a result of COVID 19 lockdown backlog, a statistical surge in the number of patients presenting with hypermature cataract and its complications was observed  . Change in outlook of patient  during the pandemic towards seeking medical attention   was the most important factor for late presentation.

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
475 Views
86 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved